| GeneName |
Symbol |
Polymorphism |
African-American Data |
Phenotypes |
Reference |
| Apolipoprotein E |
APOE |
Epsilon (E2, E3, E4) |
No diff for any phenotype after adjusting |
dementia, Alzheimer's disease (AD), and vascular dementia (VaD) |
Fitzpatrick AL. J Am Geriatr Soc 2004, 52(2):195-204. |
| Apolipoprotein E |
APOE |
Epsilon (E2, E3, E4) |
Cognitive impairment neg assoc with E2, but E4 reduced risk for Alz in Af-Caribbean |
Alz, Vascular Dis |
Stewart R, Dement Geriatr Cogn Disord 2001, 12(4):251-6. |
| Apolipoprotein E |
APOE |
Epsilon (E2, E3, E4) |
E2 and Reduced LDL levels |
LDL. HDL, tot Chol, Triglycerides |
Pablos-Mendez A, Arterioscler Thromb Vasc Biol. 1997, 17(12):3534-41. |
| Peroxisome Proliferator-Activated Receptor Gamma |
PPARgamma |
Pro12Ala (replaces alinine for Proline at condon 12 at amino-terminus of the PPARgamm2 isoform) |
No African American data:
Findings:
*Amino Acid substitution associated with lower BMI-index (Deep et al 1998).
*Pro/Pro genotype associated with T2DM (Ren et al, 2002).
*5 subsequent studies (Mancini et al, 1999; Ringel et al, 1999; Clement et al, 2000; Hara et al, 2000; Meirhaeghe et al, 2000) could not verify these findings.
*Altshuler et al (2000) evaluated 16 published articles comparing them to family controls. Found modest association between Pro allele and diabetes.
|
Insulin resistence; BMI |
Literature Review: Gurnell M. 2003. Clinical Endocrinology 59: 267-277. |
| |
PPARgamma |
Pro12Ala |
No African American data:
Findings:
*Whole body insulin sensitivity was improved for carriers of the of the Ala allele.
*No association between genotype and Type II diabetes
|
Whole body insulin senstivity (measured in two different ways); type II diabetes |
Ek J et al. Diabetologia 2001, 44: 1170-76 |
PPAR-gamma- Coactivator 1 |
PGC-1 |
Gly482Ser |
No African American data:
Findings:
*Pima Indians (sample);
*No association with either type 2 diabetes or BMI;
*Gly/Gly genotypes had a ower mean insulin secretory response to intravenous and oral glucose, and a lower mean rate of lipid oxidation despite a larger mean abdominal adipocyte size a higher mean plasma free fatty acid concentration.
|
Diabetes related phenotypes |
Muller YL et al. Diabetes 2003, 52: 895-898. |
| |
PGC-1 |
tested: 7 polymorphisms and Gly482Ser was the only significant one. |
No African American data:
Findings:
*Gly482Ser variant is more prevalent among typeII diabetic patients (1.34 genotype relative risk to Type II diabetes)
|
Type II diabetes |
Ek J et al. Diabetologia 2001, 44: 2220-2226. |
| Angiotensinogen I- Converting Enzyme |
ACE |
A/G SNP |
No A.A. Population is Africans and White Americans |
hypertension, BP |
HGVbase [SNP000006569] |
| |
ACE |
old A2350G
new A11860G |
No A.A., but in Nigerians, the G allele assoc. w/ increased SBP & DBP |
SBP and ACE conc. |
Zhu X et al, Am J Hum Genet. 2001, 68:1139-1148. |
| |
ACE |
old A-240T
new A-262T |
No A.A., but in Nigerians, the T allele is assoc w/ inc. SBP & DBP |
SBP, DBP and ACE concentration |
Zhu X et al, Am J Hum Genet. 2001, 68:1139-1148. |
| |
ACE |
A11599G and
A15990G and
A20060G and A239T |
Haplotype blocks and family-based transmission/ disequilibrium tests AAAA transmitted more often in A.A. htn offspring. |
hypertension |
Zhu X et al, Hypertension 2003, 41(5): 1027-34. |
| |
ACE |
I/D |
Significant correlation w/ ACE activity; weak relationship to BP |
hypertension |
Rotimi C et al, Hypertension. 1996; 27: 558-563. |
| Angiotensinogen |
AGT |
M235T |
235T is high in A.A. as well as in Nigerians and Jamacains, relative to Whites. But hypertension is high only in A.A., relative to N & J, so a large environmental contribution. |
hypertension |
Rotimi C et al, Hypertension. 1996; 27: 558-563. |
| |
AGT |
C4072T |
Assoc w/ hyp in European and Japanese but not A.A. |
hypertension |
Rotimi C et al, Hypertension. 1994; 24: 591-594. |
| |
AGT |
5 different SNPs |
no assoc. w/ htn or AGT levels |
htn and AGT level |
Abstract: Wu X et al, J Hypertens. 2003; Oct;21 (10): 1815-8. |
| |
AGT |
M235T |
In Afro-Caribbeans, there's a significant assoc. of M235T w/ BP and cholesterol metabolism in the "genetic context" of the RH blood group system. |
BP , lipids, and lipoprotein conc. |
Abstract: Robinson MT et al, J Hum Hypertens. 2004 May; 18 (5): 351-63 |
| |
AGT |
A-217G |
Frequency of A allele was 0.29 in hypertensives and 0.19 in normotensives. |
hypertension |
Jain S et al, Journal of Biologcal Chemistry 2002 Sept; 277 No.39 (27): 36889-36896 |
| Angiotensinogen II receptor, subtype 1 |
AGTR1 |
A44221G |
G allele increases risk of hypertension. This is the only single marker that could be associated w/ htn in A.A. |
hypertension |
Zhu X et al, Hypertension.2003 May;41(5): 1027-34 |
| |
AGTR1 |
A44221G and C43732T |
This haplotype block is significantly associated w/ htn (CG is overtransmitted in htn offspring) |
hypertension |
Zhu X et al, Hypertension.2003 May;41(5): 1027-34 |
| renin |
REN |
C-4021T and
C-3212T |
This block is assoc w/ htn in A.A. with haplotype CC being transmitted less often and TC and TT transmitted more often than expected. |
hypertension |
Zhu X et al, Hypertension.2003 May;41(5): 1027-34 |
| interleukin-1B |
IL-1B |
C-511T |
no A.A. data, and no significant difference in allelic frequency btwn CAD+ and CAD- individuals |
coronary artery disease (CAD) |
Vohnout B et al, Haematologica. 2003 Jan.;88 (01): 54-60 |
| |
IL-1B |
RFLP (-511) |
In diabetic A.A. this allele is acssociated with periodontal disease. |
periodontal disease |
Guzman S et al, J Periodontol. 2003 Aug;74 (8): 1183-90 |
| |
IL-1B |
RFLP |
In A.A. influences risk of early- onset periodontitis |
early-onset pereodontitis |
Abstract: Diehl SR et al, J Periodontol. 1999 Apr;70(4): 418-30 |
| interleukin-1 |
IL-1 |
|
Candidate gene linking periodontal disease and cardiovascular disease |
periodontal disease and cardiovascular disease |
Review Abstract: Kornman KS and Duff GW, 2001. Dec; 6(1): 48-57 |
| interleukin-1 receptor antagonist |
IL1-RA |
VNTR (86bp) in intron 2 |
no A.A. data, and no significant difference in allelic frequency btwn CAD+ and CAD- individuals |
coronary artery disease (CAD) |
Vohnout B et al, Haematologica. 2003 Jan.;88 (01): 54-60 |
| |
|
ACT |
|
|
Kamboh MI,(1995). "APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism." Nat Genet. Aug;10(4):486-8.
Click here for full paper. |